21279 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
Sustained release composition containing SDF-1
#2402NANOPARTICULATE MEGESTROL FORMULATIONS
#2403Controlled release local anesthetic comprising a biologically active non-sulfated glycosaminoglycan matrix
#2404Uniform field magnetization and targeting of therapeutic formulations
#2405EDIBLE GELATIN BOWEL PREPARATION AND BOWEL CLEANSING METHOD
#2406Stabilized protein crystals, formulations comprising them and methods of making them
#2407Modified ghrelin peptides
#2408USE OF HYDROPHOBIN POLYPEPTIDES AS PENETRATION ENHANCERS
#2409MULTIFUNCTIONAL LINKERS
#2410LIPOPEPTIDES FOR DELIVERY OF NUCLEIC ACIDS
#2411Advanced availability detection
#2412Advanced availability detection
#2413Beta sheet tapes ribbons in tissue engineering
#2414System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron
#2415Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
#2416Freeze-dried plasma formats for the trauma care field
#2417MINERALIZED POLYMER PARTICLES AND THE METHOD FOR THEIR PRODUCTION
#2418COLLAGEN-CONTAINING CELL CARRIER
#2419Advanced availability detection
#2420Compositions and methods of delivery of pharmacological agents
#2421Method of preparing cross-linked bioactive hydrogel matrices
#2422Dynamic bio-nanoparticle elements
#2423Use of RGD-enriched gelatine-like proteins for inhibition of cancer metastasis
#2424Alanine-Based Peptide Hydrogels
#2425Compositions and Methods for Improved Skin Care
#2426Compositions for delivery of therapeutics and other materials
#2427Methods and compositions for treating recurrent cancer
#2428Micro-particles, blood-substitute and method for forming same
#2429Methods For Delivering Thymosin Beta 4, Analogues, Isoforms and Other Derivatives
#2430Controlled release composition comprising a recombinant gelatin
#2431Compositions and methods of delivery of pharmacological agents
#2432Protein matrix materials, devices and methods of making and using thereof
#2433COMPOSITION FOR TREATING ISCHEMIC LIMB DISEASE COMPRISING STEM CELLS DERIVED FROM ADIPOSE TISSUE
#2434IN VIVO GENE TRANSFER METHODS FOR WOUND HEALING
#2435Albumin Fusion Proteins
#2436Complex consisted of a polysaccharide and an HBP
#2437Nanoparticle comprising rapamycin and albumin as anticancer agent
#2438Hetero-assembled hydrogels
#2439Hemostatic compositions containing sterile thrombin
#2440Compositions and methods for treating the vertebral column
#2441Method for silk fibroin gelation using sonication
#2442Highly purified type A toxin preparation from infant botulism pathogen
#2443Pharmaceutical Formulations and Methods for Making the Same
#2444Biopolymeric membrane for wound protection and repair
#2445Collagen/hydroxyapatite composite scaffold, and process for the production thereof
#2446Gastric reflux resistant dosage forms
#2447Compositions for delivery of therapeutics and other materials
#2448Environment-responding siRNA carrier using disulfide-cross-linked polymeric micelle
#2449ELASTIN-LIKE POLYMER DELIVERY VEHICLES
#2450RETINOL FORMULATIONS AND METHODS FOR THEIR USE
#2451Flowable carrier matrix and methods for delivering to a patient
#2452Therapeutic ultrasound gel
#2453Compositions of activated botulinum holotoxin type B (150 kD)
#2454Compositions of activated botulinum toxin type B
#2455AGENT FOR ENHANCING THE RESISTANCE OF LIPOSOME AGAINST BIOLOGICAL COMPONENT, AND LIPOSOME MODIFIED WITH THE AGENT
#2456Humanized Viral Vectors and Methods of Use Thereof
#2457Compositions for delivery of therapeutics and other materials
#2458Topical compositions containing magaldrate
#2459Method for producing modified biopolymer and method for crosslinking biopolymer
#2460Vault and vault-like carrier molecules
#2461Flowable carrier matrix and methods for delivering to a patient
#2462Antinuclear antibody utilized as a targeting agent for pharmaceutical compounds used in the treatment of cancer and other diseases
#2463Pharmaceutical compositions containing plasma protein
#2464METHOD FOR REMOVING ORGANIC SOLVENT
#2465Methods for preparation of platelet rich plasma
#2466Orally administrable films
#2467Composition for Administration to Mammals or Human
#2468Liquid, aqueous pharmaceutical compositions of factor VII polypeptides
#2469Methods of producing nano-and microcapsules of spider silk proteins
#2470Pharmaceutical Compositions Including Low Dosages of Desmopressin
#2471Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
#2472Controlled release composition
#2473Method for prevention of platelet aggregation employing and RGD-enriched gelatine-like protein
#2474Dual variable domain immunoglobulin and uses thereof
#2475Microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics
#2476Native potato protein isolates
#2477Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
#2478SILK MICROSPHERES FOR ENCAPSULATION AND CONTROLLED RELEASE
#2479TRANSPORT OF DRUGS VIA THE BLOOD-BRAIN BARRIER BY MEANS OF APOLIPOPROTEINS
#2480Temperature controlled and pH dependent self gelling biopolymeric aqueous solution
#2481CONTROLLED RELEASE COMPOSITION AND PROCESS
#2482Devices for the Treatment of Vascular Aneurysm
#2483Diagnostic and therapeutic methods
#2484Polysaccharide gel formulation having increased longevity
#2485Protein gel formation
#2486Biocompatible and biodegradable elastomeric polymers
#2487CARTILAGE FILLING DEVICE
#2488Hydrogels Suitable For Use In Polyp Removal
#2489Pharmaceutical formulations
#2490COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#2491Multiple modified derivatives of gelatin and crosslinked material thereof
#2492Nanogenomics for medicine: siRNA engineering
#2493Protein Nanoparticles and the Use of the Same
#2494TRANSMUCOSAL DELIVERY OF PEPTIDES AND PROTEINS
#2495Albumin Fusion Proteins
#2496External Agent for Treatment of Skin Ulcer
#2497TREATMENT OF WOUNDS USING IL-17B
#2498Temperature responsive depsipeptide polymer
#2499Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds
#2500Crosslinked Gelatin Gel, Multilayered Structure, Carrier for Bioactive Factor, Preparation for Release of Bioactive Factor, and Their Production Methods
#2501Inhibitor of Insulin Multimer Formation
#2502NANOPARTICLE FORMULATIONS AND USES THEREOF
#2503PROTECTIVE HYDROCOLLOID FOR ACTIVE INGREDIENTS
#2504ELECTROSTATICALLY CHARGED NASAL APPLICATION MULTIPURPOSE PRODUCTS AND METHOD
#2505OLIGONUCLEOTIDES-TRANSFERRING PREPARATIONS
#2506TRI-MOLECULAR COMPLEXES AND THEIR USE IN DRUG DELIVERY SYSTEMS
#2507Repeat Sequence Protein Polymer Nanoparticles Optionally Containing Active Agents and Their Preparation
#2508Methods of Producing Influenza Vaccine Compositions
#2509Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
#2510CHEWABLE CAPSULES
#2511Spider silk proteins and methods for producing spider silk proteins
#2512PROCESS TO MINIMIZE POLYMORPHISM
#2513Emulsion
#2514TIGHT JUNCTION MODULATING PEPTIDE COMPONENTS FOR ENHANCING MUCOSAL DELIVERY OF THERAPEUTIC AGENTS
#2515GENE TRANSFER METHOD
#2516Pharmaceutical Composition and Dressing for Treating Skin Lesion, as Well as the Use of Cerium Salt Associated With a Collagen Matrix
#2517PROLONGED DELIVERY OF HEPARIN-BINDING GROWTH FACTORS FROM HEPARIN-DERIVATIZED COLLAGEN
#2518Use of gelatin and a cross-linking agent for producing a cross-linking therapeutic composition
#2519RGD-enriched gelatine-like proteins with enhanced cell binding
#2520Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
#2521Modified gherlin peptides
#2522Functional Masticatory Material, Method Of Producing The Same And Method Of Using The Same
#2523Embedded enzymes in polymers to regulate their degradation rate
#2524Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer
#2525Ophthalmic hGM-CSF preparation
#2526Dermal filler
#2527COMPOSITIONS AND METHODS FOR TREATING PULP INFLAMMATIONS CAUSED BY INFECTION OR TRAUMA
#2528Recombinant gelatins
#2529Polysaccharide gel formulation having increased longevity
#2530Methods for Making and Delivering Rho-Antagonist Tissue Adhesive Formulations to the Injured Mammalian Central and Peripheral Nervous Systems and uses Thereof
#2531Gelatin-containing topical composition
#2532METHODS AND COMPOSITIONS FOR TREATING DRY EYE
#2533ORAL DELIVERY VEHICLE AND MATERIAL
#2534SUBLINGUAL SPRAY FOR THE TREATMENT OF PAIN
#2535Anti-adhesion membrane
#2536Combinations and modes of administration of therapeutic agents and combination therapy
#2537INJECTABLE FORMS OF SOLID-FORMING CROSSLINKED BIOELASTIC BIOPOLYMERS FOR LOCAL DRUG DELIVERY
#2538Cell transfection array for introduction of nucleic acid
#2539Uniform field magnetization and targeting of therapeutic formulations
#2540Nanoparticulate compositions having lysozyme as a surface stabilizer
#2541STABILIZATION OF MAMMALIAN MEMBRANE PROTEINS BY SHORT SURFACTANT PEPTIDES
#2542Transmucosal delivery of peptides and proteins
#2543Oral Cephalotaxine Dosage Forms
#2544EXTERNAL PREPARATION FOR IMPROVING COITAL FUNCTION
#2545Appetite Suppressant Composition and Method of Appetite Suppression
#2546Pharmaceutical composition for obstructive vascular disease
#2547Microgel and external compositions containing the same
#2548Stabilized glycosaminoglycan preparations and related methods
#2549Peptides as cell penetrating carriers
#2550TSG101-GAG INTERACTION AND USE THEREOF
#2551CARDIOMYOPATHY THERAPEUTIC AGENT
#2552Immunomodulatory compositions, methods of making, and methods of use thereof
#2553Composition Comprising Silver Nanoparticles and the Use Thereof
#2554Pharmaceutical compositions including low dosages of desmopressin
#2555Enzymatically Crosslinked Protein Nanoparticles
#2556ISCHEMIA THERAPEUTIC AGENT
#2557Interpenetrating Networks, and Related Methods and Compositions
#2558Anti-acne skin agent for external use
#2559Method for treating allergic dermatitis
#2560GEL-BASED DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS
#2561RGD-enriched gelatine-like proteins with enhanced cell binding
#2562Pharmaceutical compositions including low dosages of desmopressin
#2563Infant Nutrition With Protease Inhibitor
#2564Albumin Fusion Proteins
#2565Albumin Fusion Proteins
#2566Albumin Fusion Proteins
#2567Albumin fusion proteins
#2568Albumin Fusion Proteins
#2569ANGIOGENESIS-PROMOTING SUBSTRATE
#2570Albumin Fusion Proteins
#2571Biocompatible hydrogels made with small molecule precursors
#2572Methods and compositions for live attenuated viruses
#2573Animal Medicament and Method of Manufacture
#2574Method and Apparatus for Ophthalmic Medication Delivery and Ocular Wound Recovery
#2575Preservation of bioactive materials by freeze dried foam
#2576Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabilized with Polypeptide Fragments Derived from HIV-TAT
#2577Stabilized protein crystals, formulations comprising them and methods of making them
#2578Biocompatible crosslinked polymers with visualization agents
#2579Methods and compositions for treatment of bone defects with placental cell populations
#2580Method for producing storage stable viruses and immunogenic compositions thereof
#2581Immobilized bioactive hydrogel matrices as surface coatings
#2582Rapidly acting dry sealant and methods for use and manufacture
#2583Nanoparticulate megestrol formulations
#2584RGD-enriched gelatines
#2585Compositions and methods for treatment of hyperplasia
#2586Cell delivery matrices
#2587COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPLASIA
#2588COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPLASIA
#2589DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS
#2590Protein stabilization formulations
#2591PROPOFOL FORMULATION CONTAINING REDUCED OIL AND SURFACTANTS
#2592Methods and compositions for treating tissue using silk proteins
#2593Albumin fusion proteins
#2594Drug delivery system comprising an RGD-enriched gelatine
#2595Use of RGD-enriched gelatine-like proteins for inhibition of cancer metastasis
#2596Preservation of bioactive materials by freeze dried foam
#2597PHARMACEUTICAL COMPOSITIONS CONTAINING BOTULINUM TOXIN
#2598Hydrogel For Medical Use
#2599Compositions and methods for topical application and transdermal delivery of botulinum toxins
#2600Non-glycosylated recombinant collagen-like polypeptides
#2601Liquid adenovirus formulations
#2602Formulation for adenovirus storage
#2603Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising them
#2604Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
#2605Protein matrix vaccines and methods of making and administering such vaccines
#2606Keratin-Based Powders and Hydrogel for Pharmaceutical Applications
#2607Silk-based drug delivery system
#2608Edible dissolving gelatin strips
#2609Methods and compositions for treating proliferative diseases
#2610Composition for Stabilizing Vitamin C in Water Phase and Method for Stabilizing C Using Thereof
#2611Flowable carrier matrix and methods for delivering to a patient
#2612Powdered Compositions Of Sensitive Active Materials In An At Least Partially Amorphous State
#2613Compositions for delivery of therapeutics and other materials
#2614SUTURES AND FIBROSING AGENTS
#2615Collagen delivery device
#2616Albumin fusion proteins
#2617Pharmaceutical Formulations for the Prolonged Release of Interferons and Their Therapeutic Applications
#2618Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
#2619Pharmaceutical compositions including low dosages of desmopressin
#2620Pharmaceutical compositions containing plasma protein
#2621Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
#2622COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS UTILIZING PROTEIN OR POLYSACCHARIDE CONTAINING ANTI-MICROTUBULE AGENTS
#2623COMPOSITION AND METHOD FOR TREATING HIV INFECTION
#2624Remedy For Diabetic Neuropathy Comprising Gelatin Gel As Carrier
#2625Proteins
#2626Hydrogels for protein concentration
#2627Pharmaceutical formulations for the prolonged release of active principle(s) and their applications
#2628Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
#2629Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
#2630Compositions and methods for treating photo damaged skin
#2631Protein hydrolysate excipients
#2632Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
#2633Compositions and methods for treating alopecia
#2634Compositions capable of facilitation penetration across a biological barrier
#2635Multivalent constructs for therapeutic and diagnostic applications
#2636Nucleic acid sequences encoding D1 and D1/D2 domains of human coxsackievirus and adenovirus receptor (CAR)
#2637Protein-Stabilized Liposomal Formulations of Pharmaceutical Agents
#2638Propofol formulation containing reduced oil and surfactants
#2639Methods of Producing Influenza Vaccine Compositions
#2640TIGHT JUNCTION MODULATING PEPTIDES FOR ENHANCED MUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS
#2641Gastric reflux resistant dosage forms
#2642COMPOSITION FOR INTESTINAL DELIVERY
#2643Stable capsule preparation
#2644POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY
#2645COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS
#2646Hydrogels and uses thereof
#2647POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS
#2648G-CSF CONJUGATES
#2649Probiotic storage and delivery
#2650Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
#2651Methods and compositions for treating proliferative diseases
#2652Compositions for disrupting and inhibiting reconstitution of wound biofilm
#2653Hydrogel compositions
#2654Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#2655Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#2656Pharmaceutical compositions containing botulinum toxin
#2657Particulate acellular tissue matrix
#2658Compositions and methods for improved skin care
#2659Formulations for topical delivery of bioactive substances and methods for their use
#2660Dual variable domain immunoglobulin and uses thereof
#2661Composition for intracellular transport of biological particles or macromolecules
#2662TREATMENT OF WOUNDS USING IL-17B
#2663Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions
#2664Stabilizers for veterinary vaccines
#2665Neoglycopolymer-cross-linked biopolymer matrix
#2666Botulinum toxin compositions
#2667Paclitaxel-based antitumor formulation
#2668Remedy for cardiomyopathy
#2669Direct drug delivery system based on thermally responsive biopolymers
#2670Non-adhesive hydrogels
#2671G-CSF CONJUGATES
#2672Contrast agents
#2673G-CSF Conjugates
#2674Silk fibroin materials and use thereof
#2675G-CSF CONJUGATES
#2676G-CSF CONJUGATES
#2677Combinations and modes of administration of therapeutic agents and combination therapy
#2678Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
#2679Site-specific gene conversion promoter and gene therapeutic
#2680Powderous formulations of fat-soluble active ingredients
#2681Directly injectable formulations which provide enhanced cryoprotection of cell products
#2682Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
#2683RGD-enriched gelatine-like proteins with enhanced cell binding
#2684Methods for modulating topical inflammatory response
#2685Liposome compositions
#2686Templated native silk smectic gels
#2687Formulations and methods for delivery of growth factor analogs
#2688Liquid, aqueous pharmaceutical compositions of factor VII polypeptides
#2689Edible dissolving gelatin strips
#2690Hemostatic compositions containing sterile thrombin
#2691External preparation for improving coital function
#2692Remedy for ischemia
#2693High-potency botulinum toxin formulations
#2694Stabilized protein compositions for topical administration and methods of making same
#2695Collagen gel and process of producing the same
#2696Hypercoiling polymers and their use in cellular delivery
#2697Methods and compositions for enhanced transmucosal delivery of peptides and proteins
#2698Sustained release preparation for therapy of coronary stenosis or obstruction
#2699Vault and vault-like carrier molecules
#2700Biocompatible crosslinked polymers with visualization agents